Gastroenterology 74(6):12241228
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-comparator-controlled, parallel-group, phase 2 trial conducted in the USA
Stubborn fat in the abdomen, arms, or thighs can distort the bodys natural silhouette
Browse our most frequently asked questions below to get all of your questions answered
Benefits may include: Faster healing of soft tissue injuries Reduced joint discomfort Gastrointestinal protection Peptide systems like Pet MatRx often include compounds like BPC-157 that activate similar repair pathways, supporting digestive balance and cellular resilience from the inside out
Cagrilintide + Retatrutide Reconstitution Guide Reconstitution math is different for the pre-blend versus two separate vials